SMi’s 4th annual Pharmacovigilance, Drug Safety & Risk Management conference will take place on the 11th & 12th May 2015 in Central London, UK

LONDON, ENGLAND, UNITED KINGDOM, January 13, 2015 /EINPresswire.com/ -- SMi group are delighted to announce that registration is now live to attend the 4th annual conference on Pharmacovigilance, Drug Safety & Risk Management, taking place on 11th - 12th May in Central London UK. This event will ask questions such as: How do we strengthen the link between a drug and its related adverse events from pre-clinical to post-marketing? What are the core and emerging challenges of adhering to Pharmacovigilance laws and risk management? Can we communicate benefits and risks to patients? How is the EudraVigilance system implemented in the pre and post-marketing approval of medicinal drugs? How can we harmonise coding for EU and US markets?

Key Speakers Include:

• Graeme Ladds, CEO, Director of Operations, Pharmacovigilance, PharSafer Associates Ltd
• Dr. Pipasha Biswas, Executive Director & QPPV, Symogen Ltd
• Jim Slattery, Statistician, Pharmacovigilance, European Medicines Agency (EMA)
• Dr. Tomas Moraleda , International Medical Officer, MedDRA MSSO
• Doris Irene Stenver, Chief Medical Officer, Danish Health and Medicines Authority, Member of PRAC
• Dr. Michael Merz, Chair Investigative Liver Expert Team, Novartis Institutes for Biomedical Research
• Shelley Gandhi, Director of Pharmacovigilance and Drug Safety, NDA Group

A brochure is available to download at http://www.smi-online.co.uk/goto/2015pharmacovigilance1.asp

Attend this event to:

• Hear EMA KEYNOTE ADDRESS: Risk Management through Statistical Integration
• Understand the EU’s harmonisation initiatives through MedDRA and Eudravigilance
• Optimise the outcome of risk assessments and risk minimisation measures
• Learn new PRAC updates for 2015
• Efficiently bridge preclinical to clinical safety data

In addition, don’t miss the 2 interactive post conference workshops taking place on the 13th May 2015: MedDRA Coding Guidelines (Hosted by Dr. Tomas Moraleda, International Medical Officer, MedDRA MSSO) and Risk Minimisation and Signal Management (Hosted by Graeme Ladds, CEO, Director of Operations, Pharmacovigilance, PharSafer Associates Ltd)

For those who are interested in attending, there is currently a £300 discount available online. Visit http://www.smi-online.co.uk/goto/2015pharmacovigilance1.asp

-------------------------- END --------------------------

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the worlds most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Teri Arri
SMi Group Ltd
+44 (0) 20 7827 6162
email us here